Search
OPKO Health Inc
OPKAdd to Watchlist
1.645USD
-0.055-3.23%
Market hours 09/24, 12:57（ET）
1.23BMarket Cap
LossP/E TTM
About OPKO Health Inc Company
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
OPKO Health Inc Profile
Ticker SymbolOPK
Company nameOPKO Health Inc
IPO dateNov 02, 1995
CEOCruz (Tony F)
Number of employees2997
Security typeOrdinary Share
Fiscal year-endNov 02
Address- -
City- -
Stock exchangeNASDAQ OMX - NASDAQ BASIC
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolOPK
IPO dateNov 02, 1995
CEOCruz (Tony F)
Company Executives of OPKO Health Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Subbarao V. Uppaluri, Ph.D.
Dr. Subbarao V. Uppaluri, Ph.D.
Independent Director
Independent Director
3.16M
--
Dr. Subbarao V. Uppaluri, Ph.D.
Dr. Subbarao V. Uppaluri, Ph.D.
Independent Director
Independent Director
3.16M
--
Dr. Subbarao V. Uppaluri, Ph.D.
Dr. Subbarao V. Uppaluri, Ph.D.
Independent Director
Independent Director
3.16M
--
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
125.90K
-42.31%
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
125.90K
-42.31%
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
125.90K
-42.31%
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
103.33K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Subbarao V. Uppaluri, Ph.D.
Dr. Subbarao V. Uppaluri, Ph.D.
Independent Director
Independent Director
3.16M
--
Dr. Subbarao V. Uppaluri, Ph.D.
Dr. Subbarao V. Uppaluri, Ph.D.
Independent Director
Independent Director
3.16M
--
Dr. Subbarao V. Uppaluri, Ph.D.
Dr. Subbarao V. Uppaluri, Ph.D.
Independent Director
Independent Director
3.16M
--
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
125.90K
-42.31%
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
125.90K
-42.31%
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
125.90K
-42.31%
FAQs
Who are the top five shareholders of OPKO Health Inc?
The top five shareholders of OPKO Health Inc are: Dr. Subbarao V. Uppaluri, Ph.D.
How many institutions hold shares of OPKO Health Inc (OPK)?
As of 2026Q1, 451 institutions hold shares of OPKO Health Inc, with a combined market value of approximately 236.82M, accounting for 31.36% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -9382421.00.
What is the biggest source of revenue for OPKO Health Inc?
In 2026Q1, the Health Insurers business generated the highest revenue for OPKO Health Inc, amounting to 49.99M and accounting for 67.06% of total revenue.